Donate

2026-2027 Awards & Grants Funding Cycle Underway

Investing in Next Generation of Lung Health Breakthroughs

The American Lung Association Research Institute’s Awards & Grants Program supports promising scientists whose discoveries are advancing the prevention, diagnosis and treatment of lung disease. For more than 120 years, the Lung Association has played a critical role in advancing research that has transformed patient care and improved millions of lives.

As the 2026–2027 funding cycle moves forward, we look ahead to another year of investing in innovative research that will shape the future of lung health. To learn more about our funding process, visit: Lung.org/awards

Spotlight on Awardees

With 46 projects receiving funding as part of this latest cycle, we are currently funding a total of 120 awards. Here are a few highlights of the newly funded researchers and their projects. 

Mary Berlik Rice, MD, MPH

Mary Berlik Rice, MD, MPH, Harvard T. H. Chan School of Public Health

Indoor Air Research Award: Purifying Indoor Air of Biological and Chemical Pollutants to Enhance Respiratory Health in Eosinophilic COPD

Could cleaner indoor air help people with COPD breathe easier? This study is testing whether HEPA air purifiers reduce harmful pollutants in the home and improve lung function, symptoms and quality of life. 

James Kim, MD, PhD

James Kim, MD, PhD, The University of Texas Southwestern Medical Center

Lung Cancer Discovery Award: Epithelial to Neuronal Transition as a Driver of SCLC Brain Metastasis

Studying how small cell lung cancer (SCLC) spreads to the brain, where treatment options are limited, this research could identify new targets for therapies that prevent or slow brain metastases. It hopes to improve outcomes for people with this aggressive disease.

Filiz Korkmaz, PhD

Filiz Korkmaz, PhD, The University of Iowa

Innovation Award: Mechanisms of Lung Repair through LOX-1+ Neutrophils and B Cell Crosstalk

Healthy immune cells play an important role in protecting the lungs from damage during pneumonia. By uncovering how these cells reduce inflammation and promote healing, this research could inspire new therapies that improve recovery after serious lung infections.

Jarrod Mousa, PhD

Jarrod Mousa, PhD, Florida State University Research Foundation, Inc.

Emerging Respiratory Pathogen Award: Insights into Breast Milk Antibodies Induced by Respiratory Viruses

This project explores how maternal Respiratory Syncytial Virus (RSV) vaccination and breast milk work together to protect infants from severe RSV infection. Findings aim to improve maternal vaccines, strengthen newborn immunity and better prepare for future respiratory virus threats.

Feroze Ganaie, PhD, MBA

Feroze Ganaie, PhD, MBA, University of Alabama at Birmingham

Catalyst AwardInvestigating Mechanisms of Pneumococcal Vaccine Failure in COPD

This project investigates why certain strains of the bacteria that cause pneumonia can evade existing vaccines, even in vaccinated people. Findings could lead to more effective vaccines and help reduce serious lung infections, especially among older adults with chronic lung disease. 

Caroline Sokol, MD, PhD

Caroline Sokol, MD, PhD, Massachusetts General Hospital

ALA/AAAAI Allergic Respiratory Diseases Research Award: Sensory Neuronal Control of CD4+ Tissue-Resident Memory in Allergic Inflammation

Asthma attacks are fueled by immune cells that “remember” past allergen exposure and react quickly when triggered. This project examines how nerves in the lungs activate these cells, opening the door to therapies that could prevent asthma flare-ups before they begin.

Page last updated: July 24, 2026

LUNG FORCE Walk - Cleveland
Cleveland, OH | Sep 27, 2026